Institutional investors purchased a net $115.1 thousand shares of OGEN during the quarter ended September 2017. This may signal that the smart money is gaining interest in this company as the 8.31% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE BANK OF NEW YORK MELLON CORP... Bought 200.0 Thousand shares of Oragenics Inc